Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Drinks Industry News How Kirin’s pivot to healthcare could reshape the future of Four Roses bourbon Kirin Holdings is reportedly considering selling the Four Roses bourbon brand for around US$1 billion. Find out the strategic reasons behind the move. byPallavi MadhirajuOctober 26, 2025